ASLN - ASLAN Pharmaceuticals Ltd - ADR
Close
0.6
-0.100 -16.650%
Share volume: 806,352
Last Updated: Thu 18 Jul 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.10
-14.27%
Summary score
39%
Profitability
50%
Dept financing
21%
Liquidity
50%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
97.98%
Return on assets
-16.18%
Return on sales
-216.83%
Return on invested capital
83.01%
Total debt ratio
51.67%
Debt ratio change over timeo
-1.47%
Current Ratio
10.1%
Quick Ratio
0%
Cash Position Ratio
7.21%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
461.73%
Return on assets
-21.19%
Return on sales
0%
Return on invested capital
221.41%
Total debt ratio
112.83%
Debt ratio change over timeo
-1.96%
Current Ratio
3.43%
Quick Ratio
0%
Cash Position Ratio
3.39%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
45.16%
Return on assets
-24.55%
Return on sales
0%
Return on invested capital
112.14%
Total debt ratio
158.52%
Debt ratio change over time
0.48%
Current Ratio
3.23%
Quick Ratio
0%
Cash Position Ratio
3.16%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-500.37%
Return on assets
-84.35%
Return on sales
-9.53%
Return on invested capital
-207.69%
Total debt ratio
-146.9%
Debt ratio change over time
-1.47%
Current Ratio
-2.52%
Quick Ratio
0%
Cash Position Ratio
-3.13%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ASLN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 97.98% | -3.05% | 11.55% | 6.27% |
| Return on assets | -16.18% | 3.6% | 3.57% | 5.27% |
| Return on sales | -216.83% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 83.01% | 5.09% | 7.99% | 13.19% |
| Profitability | 50% | 38% | 47% | 50% |
| Total debt ratio | 51.67% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.47% | 6.09% | 6.03% | 1.53% |
| Dept financing | 13% | 50% | 43% | 14% |
| Current Ratio | 3.43% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.39% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 17% | 36% | 36% |
| Short-term ratios | ASLN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 461.73% | -25.62% | 17.94% | 7.14% |
| Return on assets | -21.19% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 221.41% | 8.14% | 7.17% | 18.16% |
| Profitability | 50% | 39% | 46% | 50% |
| Total debt ratio | 112.83% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.96% | -23.44% | 9.66% | 0.6% |
| Dept financing | 25% | 23% | 43% | 8% |
| Current Ratio | 3.43% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.39% | 1.48% | 0.76% | 1.49% |
| Liquididy | 49% | 43% | 35% | 61% |